STOCK TITAN

Glaukos Corp (GKOS) CFO exercises options and sells 20,000 shares under 10b5-1 plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Glaukos Corp senior vice president and chief financial officer Alex R. Thurman reported an options exercise and same-day sale of common stock. On August 7, 2026, he exercised stock options for 20,000 shares of common stock at an exercise price of $33.81 per share and acquired those shares, then sold 20,000 shares of common stock at a weighted average price of $180.13 per share in a sale in open market or private transactions. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2025. Following these transactions, his reported holdings include 5,230 restricted stock units that have not yet vested or been delivered and 225 stock units purchased through the Employee Stock Purchase Plan.

Positive

  • None.

Negative

  • None.
Insider Thurman Alex R.
Role SVP & CHIEF FINANCIAL OFFICER
Sold 20,000 shs ($3.60M)
Approx. gross sale proceeds $3.60M
Approx. exercise cost $676K
Approx. pre-tax spread $2.93M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F4, F5 20,000 $0.00 $0.00
Exercise Common Stock F1 20,000 $33.81 $676K
Sale Common Stock F2, F3, F1 20,000 $180.13 $3.60M
Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 43,906 shares (Direct)
Footnotes (5)
  1. F1. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
  2. F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
  3. F3. This transaction was executed in multiple trades at prices ranging from $180.00 to $180.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. F4. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
  5. F5. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Options exercised 20,000 shares Stock options for common stock exercised by CFO on August 7, 2026
Exercise price $33.81 per share Exercise price of stock options converted into common stock
Shares sold 20,000 shares Common stock sold in open market or private transactions
Sale price (weighted average) $180.13 per share Weighted average sale price across trades from $180.00 to $180.42
Unvested RSUs 5,230 units Restricted stock units not yet vested or delivered to the reporting person
ESPP stock units 225 units Stock units purchased through the Employee Stock Purchase Plan
Rule 10b5-1 trading plan regulatory
"The sales reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 5,230 restricted stock units that have not yet vested"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"

FAQ

What insider transactions did Glaukos (GKOS) CFO Alex R. Thurman report?

Alex R. Thurman reported exercising options for 20,000 shares at $33.81 and selling 20,000 shares of Glaukos common stock at a weighted average price of $180.13 per share on August 7, 2026.

Were the recent GKOS insider trades by the CFO under a Rule 10b5-1 plan?

Yes. Both the option exercises and the sale of 20,000 shares by Glaukos CFO Alex R. Thurman were effected under a Rule 10b5-1 trading plan adopted on December 15, 2025.

At what prices did the GKOS CFO exercise and sell his Glaukos shares?

He exercised stock options at an exercise price of $33.81 per share and sold 20,000 shares of Glaukos common stock at a weighted average price of $180.13 per share, based on multiple trades between $180.00 and $180.42.

How many Glaukos (GKOS) shares did the CFO sell in this Form 4 filing?

Glaukos CFO Alex R. Thurman reported selling 20,000 shares of common stock in a sale in open market or private transactions, following the exercise of options covering the same 20,000 shares on August 7, 2026.

What equity awards does the Glaukos (GKOS) CFO still hold after these transactions?

Post-transaction holdings reported include 5,230 restricted stock units that have not yet vested or been delivered and 225 stock units acquired through Glaukos’s Employee Stock Purchase Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thurman Alex R.

(Last)(First)(Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP & CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/07/2026M20,000A$33.8163,906(1)D
Common Stock08/07/2026S(2)20,000D$180.13(3)43,906(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$33.8108/07/2026M20,000(4) (5)12/14/2026Common Stock20,000$00D
Explanation of Responses:
1. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
3. This transaction was executed in multiple trades at prices ranging from $180.00 to $180.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.
5. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
/s/ Diana Scherer, Attorney-in-Fact08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)